Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/26/2025

Management of Leg Tingling After Stopping Depakote

Diagnostic Considerations

  • The American Academy of Child and Adolescent Psychiatry suggests that the return of the original psychiatric condition for which Depakote was prescribed should be considered as an alternative explanation for leg tingling, especially if symptoms appear after discontinuation 2, 3
  • The timing of symptoms appearing 1 month after stopping Depakote falls within the expected window for withdrawal phenomena, and the American Academy of Child and Adolescent Psychiatry recommends evaluating the patient for medication reinitiation with proper tapering if symptoms are significantly impacting quality of life 1

Management Algorithm

  • The American Academy of Child and Adolescent Psychiatry recommends that if symptoms are mild and tolerable, reassurance should be provided that withdrawal symptoms typically resolve over days to weeks, and close monitoring for symptom progression or development of more concerning features is necessary 1, 2, 3
  • If symptoms are moderate to severe or impacting quality of life, the American Academy of Child and Adolescent Psychiatry suggests considering restarting Depakote at the previous dose and implementing a proper gradual taper, as the most effective intervention for medication withdrawal is resuming the medication and tapering more slowly 1, 2, 3

Critical Assessment Steps

  • The American Academy of Child and Adolescent Psychiatry recommends reviewing the medication discontinuation history to determine if Depakote was tapered gradually or stopped abruptly, and to identify all other psychiatric medications that were discontinued and their timeline 2, 3
  • The Society of Critical Care Medicine suggests evaluating for serious neurological causes, such as peripheral neuropathy, and assessing for vitamin deficiencies (B12, folate) that may have been masked during treatment, as well as considering electrolyte abnormalities if there were gastrointestinal symptoms during withdrawal 2, 4

Monitoring Plan

  • The American Academy of Child and Adolescent Psychiatry recommends close follow-up, with symptoms monitored for progression or resolution over the next 2-4 weeks, and immediate medical evaluation if severe symptoms (seizures, severe confusion, inability to function) develop 2, 3, 4

REFERENCES

1

practice parameter on the use of psychotropic medication in children and adolescents. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

2

practice parameter on the use of psychotropic medication in children and adolescents. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

3

Withdrawal Risk Assessment for Missed Medication [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025